DEAPRIL-ST Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Deapril-st, and when can generic versions of Deapril-st launch?
Deapril-st is a drug marketed by Bristol Myers Squibb and is included in one NDA.
The generic ingredient in DEAPRIL-ST is ergoloid mesylates. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergoloid mesylates profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Deapril-st
A generic version of DEAPRIL-ST was approved as ergoloid mesylates by SUN PHARM INDUSTRIES on October 31st, 1991.
Summary for DEAPRIL-ST
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 4 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | DEAPRIL-ST at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for DEAPRIL-ST
US Patents and Regulatory Information for DEAPRIL-ST
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol Myers Squibb | DEAPRIL-ST | ergoloid mesylates | TABLET;SUBLINGUAL | 085020-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
